Evidence map›Paper›PMID 35399431›Full record

ArticleCureus2022

Post-operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma.

Jennifer C Hall, Steven D Chang, Thomas J Wilson, Kristen N Ganjoo, Angus Toland, Hannes Vogel, Erqi L Pollom, Elham Rahimy

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jennifer C HallDepartment of Radiation Oncology, Stanford University, Stanford, USA.
Steven D ChangDepartment of Neurosurgery, Stanford University, Stanford, USA.
Thomas J WilsonDepartment of Neurosurgery, Stanford University, Stanford, USA.
Kristen N GanjooDepartment of Medical Oncology, Stanford University, Stanford, USA.
Angus TolandDepartment of Clinical Pathology, Stanford University, Stanford, USA.
Hannes VogelDepartment of Clinical Pathology, Stanford University, Stanford, USA.
Erqi L PollomDepartment of Radiation Oncology, Stanford University, Stanford, USA.
Elham RahimyDepartment of Radiation Oncology, Stanford University, Stanford, USA.
Stanford Medicine · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanotic schwannoma is an extremely rare schwannoma variant with malignant potential, demonstrating high local and distant recurrence. Given the paucity of data, recommended treatment with localized disease is radical resection, with the unclear benefit of adjuvant therapy. We present a case of an 18-year-old female with no past medical history or genetic syndromes who underwent margin-positive resection of an S1 nerve root melanotic schwannoma followed by adjuvant stereotactic radiosurgery (SRS). SRS was delivered without acute or late toxicity by 2.5 years post-treatment. She remains without evidence of recurrent disease, although longer follow-up is needed given the risk of late recurrence. Our case adds to the limited literature documenting the efficacy of adjuvant radiotherapy in melanotic schwannoma and is the first to describe the successful use of SRS for this rare disease.

Indexed as

adjuvant therapymelanotic schwannomaperipheral nerve sheath tumorradiationradiotherapystereotactic radiosurgery

Identifiers

PMID35399431
PMCPMC8980252
OpenAlexW4214829783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.